GlySure
Abingdon, Oxfordshire, United Kingdom
About GlySure
GlySure has developed a continuous intravascular glucose monitoring system using a proprietary optical fluorescence sensor to meet the $2B+ worldwide demand for implementation of Tight Glycemic Control (TGC) in the hospital Intensive Care Unit (ICU). The company has demonstrated through ICU testing highly accurate sensors which can provide continuous glucose readings throughout the length of a patient’s stay in the ICU.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $24.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2012)
- Website: glysure.com
- Phone: 44 12 3546 2870
Industries & Categories
Health Care, Hospital, Sensor
Social Profiles
Canonical: https://fsome.com/organization/glysure-2577951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.